Close the acquisition of Guangxi Tianyuan New Energy Materials Co., Ltd
Delivered after the deadline (208 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 30 Sep 2021
- Due
- 31 Mar 2022
- Delivered
- 25 Oct 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Albemarle expects the transaction, which is subject to customary closing conditions, to close in early 2022.”
What we found
Evidence strength A What the grades mean
Albemarle announced an expectation to close the acquisition in early 2022, but the transaction was not completed until October 25, 2022.
-
A Albemarle Corporation 10-Q filed 2022-11-02
“On October 25, 2022 the Company completed the acquisition of all of the outstanding equity of Guangxi Tianyuan New Energy Materials Co., Ltd.” ✓ confirmed on the page
Market reaction: the shares moved +4.3% against the S&P 500 over the three sessions around the disclosure (1 Nov 2022 to 4 Nov 2022). What this measures
Checked 18 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Guangxi Tianyuan New Energy Materials Co., Ltd.
- Where
- China
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to customary closing conditions
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Albemarle Corporation? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ALB-014416 · Corrections policy